Zobrazeno 1 - 10
of 2 948
pro vyhledávání: '"PEGFILGRASTIM"'
Autor:
Yoichiro Hijikata, MD, Kazuna Kawabata, MD, PhD, Suzune Tsukamoto, MD, Shunsuke Ito, MD, Saya Ando, MD, Kazuhiro Bandai, MD, Mitsumasa Watanabe, MD, PhD, Makoto Hosono, MD, PhD
Publikováno v:
Radiology Case Reports, Vol 19, Iss 9, Pp 3949-3951 (2024)
A 72-year-old man with diffuse large B-cell lymphoma underwent fluorine-18 fluorodeoxyglucose (FDG) PET/CT, revealing lymphoma lesions and no evidence of aortitis. The patient received chemotherapy and was treated with granulocyte colony-stimulating
Externí odkaz:
https://doaj.org/article/3176b8a1baf84062be21b1ba0a9e8aeb
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Background The chemotherapy regimens recommended for both rhabdomyosarcoma (RMS) and Ewing sarcoma (ES) patients are myelosuppressive and can reduce the absolute neutrophil count (ANC) and subsequently increase the risk of febrile neutropeni
Externí odkaz:
https://doaj.org/article/e25b28e249964b109bec95e8bb00fd94
Autor:
Barbara Loteta, Annalisa Pitino, Martina Pitea, Caterina Alati, Giovanni Tripepi, Maria Caterina Mico', Maria Pellicano', Francesca Cogliandro, Gaetana Porto, Giorgia Policastro, Giovanna Utano, Ilaria Maria Delfino, Annalisa Sgarlata, Anna Scopelliti, Aurora Idato, Giovanni Laenza, Maria Altomonte, Graziella D'Arrigo, Mercedes Gori, Massimo Martino
Publikováno v:
Frontiers in Hematology, Vol 3 (2024)
ObjectivesTo evaluate the efficacy of biosimilar (BIO) pegfilgrastim (PEG) in lymphoma patients after autologous stem cell transplantation (ASCT).Methods86 consecutive lymphoma patients who received BIO/PEG after ASCT were assessed. The primary endpo
Externí odkaz:
https://doaj.org/article/75271c232043486098d7ca8015c0fcd2
Autor:
Keita Miura, Ou Yamaguchi, Keita Mori, Atsushi Nakamura, Motohiro Tamiya, Tomohiro Oba, Noriko Yanagitani, Hideaki Mizutani, Takashi Ninomiya, Tomosue Kajiwara, Kentaro Ito, Akihiko Miyanaga, Daisuke Arai, Hiroaki Kodama, Kunihiko Kobayashi, Kyoichi Kaira
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Ramucirumab plus docetaxel (RD) can cause febrile neutropenia (FN), which frequently requires the prophylactic administration of pegfilgrastim. However, the effects of prophylactic pegfilgrastim on FN prevention, therapeutic efficacy, and pr
Externí odkaz:
https://doaj.org/article/2b814dbbea994c51a018f1a190fff4f2
Publikováno v:
Clinical Dermatology Review, Vol 8, Iss 2, Pp 149-153 (2024)
Acute methotrexate (MTX) toxicity is most commonly due to overdose of the drug, which may be due to the patient's noncompliance to doctor's orders or physician's prescription error. Other causes include acute renal failure, concomitant use of other d
Externí odkaz:
https://doaj.org/article/b0270a51943c423fb859f812ba0fc2cf
Autor:
Motoki Sekikawa, Haruyasu Murakami, Meiko Morita, Kosei Doshita, Keita Miura, Hiroaki Kodama, Noboru Morikawa, Yuko Iida, Nobuaki Mamesaya, Haruki Kobayashi, Ryo Ko, Kazushige Wakuda, Akira Ono, Hirotsugu Kenmotsu, Tateaki Naito, Hirofumi Chiba, Toshiaki Takahashi
Publikováno v:
Thoracic Cancer, Vol 14, Iss 35, Pp 3475-3482 (2023)
Abstract Background Amrubicin (AMR) regimens have shown efficacy as second‐line treatment in patients with small cell lung cancer (SCLC); however, adverse events such as febrile neutropenia (FN) sometimes preclude their use. Further, the safety and
Externí odkaz:
https://doaj.org/article/4fa201b940bf4f3497e40475cb88b5de
Autor:
Takanori Ito, Osamu Kanai, Zentaro Saito, Takuma Imakita, Issei Oi, Kohei Fujita, Hiromasa Tachibana, Tadashi Mio
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 1466-1474 (2023)
Introduction: Granulocyte colony-stimulating factor (G-CSF), including pegfilgrastim, increases the peripheral blood leukocyte count and is widely used in clinical practice in combination with cytotoxic chemotherapy. The most frequent side effects of
Externí odkaz:
https://doaj.org/article/297968c5326046db85425b92b92ce71f
Autor:
Toshimi Takano, Mitsuya Ito, Takayuki Kadoya, Tomofumi Osako, Tomoyuki Aruga, Norikazu Masuda, Toshiko Miyaki, Naoki Niikura, Daisuke Shimizu, Yuichi Yokoyama, Manabu Watanabe, Masato Tomomitsu, Kenjiro Aogi
Publikováno v:
Cancer Medicine, Vol 12, Iss 20, Pp 20242-20250 (2023)
Abstract Introduction Pegfilgrastim is indicated to decrease the incidence of chemotherapy‐induced febrile neutropenia. It is the first granulocyte‐colony stimulating factor approved for prophylactic use regardless of carcinoma type and is market
Externí odkaz:
https://doaj.org/article/321b17bf2623432292b885a86ad9cfd3
Autor:
Yurie Seto, Tadaaki Yamada, Masashi Egami, Takumi Sugimoto, Izumi Sato, Satomi Tanaka, Yusuke Chihara, Kenji Morimoto, Masahiro Iwasaku, Shinsaku Tokuda, Yoshiko Kaneko, Koichi Takayama
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 771-778 (2023)
With the increased use of granulocyte colony-stimulating factor (G-CSF) preparations, there is concern about the increase in G-CSF-associated large-vessel vasculitis; however, there have been no previous reports of vasculitis caused by multiple types
Externí odkaz:
https://doaj.org/article/8de460cd49764d19b7f9827d6c45fae5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.